Immunotherapy in Cancer Management: A Literature Review of Clinical Efficacy of Pembrolizumab in the Non-small Cell Lung Cancer Treatment

• Published in: Advanced pharmaceutical bulletin Vol. 13; no. 1; pp. 88 - 95
• Main Authors: Miquelotti, Luísa Biscaglia, Sari, Marcel Henrique Marcondes, Ferreira, Luana Mota
• Format: Journal Article
• Language: English
• Published: Iran Tabriz University of Medical Sciences 01.01.2023
• Subjects: anti-ctl4; anti-pd-1; Apoptosis; Cancer therapies; Chemotherapy; Clinical trials; Cytotoxicity; Health care; Immune system; Immunology; Immunotherapy; Ligands; Literature reviews; Lung cancer; Lymphocyte receptors; Lymphocytes; Medical prognosis; Mini Review; Monoclonal antibodies; non-small cell lung cancer; pembrolizumab; Tumors; Pembrolizumab; Anti-PD-1; Immunotherapy; Non-small cell lung cancer; Anti-CTL4

Purpose: Cancer is a global public health problem that affects millions of people every year and the immunotherapy has been a promising alternative for its treatment. The aim of this study was to gather data concerning the efficacy and safety of immunotherapy in the treatment of non-small cell lung...